Shortly after the demonstration of a therapeutic effect of streptomycin upon tuberculous infections in animals (1, 2) and in the human (3), Youmans and his co-workers (4) found that cultures from patients subsequent to such specific therapy yielded organisms which were resistant to streptomycin. These investigators not only observed that 7 of 8 strains recovered from 12 patients before and after treatment with streptomycin exhibited an increase in resistance of from 500-to 1,000-fold compared to tests performed prior to initiation of therapy, but they also showed that the resistance of two strains of Mycobacterium tuberculosis, one of the human type and one of the avian type, increased more than 1,000-fold when the organisms were exposed to streptomycin in vitro.
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The development of such resistance, or perhaps better expressed as loss of sensitivity, of the tubercle bacillus during streptomycin therapy has recently been studied in a joint program 
METHODS
A group of 16 patients with pulmonary tuberculosis was treated with 1.8 grams per day of streptomycin in 6 divided doses until late in the course of treatment when the same daily amount of streptomycin was divided into 5 doses, omitting the 3 :00 a.m. dose. In most instances, treatment was discontinued after four months. Eight of these patients also had ulcerative tuberculous bronchitis.
Sputa or gastric washings were collected at routine intervals. Tubercle bacilli were isolated from these specimens by inoculation of the neutralized alkaline concentrate on Hohn's and egg yolk media. After satisfactory growth had been obtained, transfer of part of a suitable colony was made to a tube of modified Dubos-Davis medium (5, 6) with a nichrome. spatula, mashing and triturating the colony in the medium in order to give as diffuse a suspension as possible. Later on in the work it was found desirable routinely to add penicillin (20 units per cc.) to the Dubos medium used for first transfer from the solid slants in order to prevent contamination with gram positive cocci. After a growth period of from 7 to 10 days at 370 C., tubercle bacilli grew in a lacey pattern at the bottom of the At the end of the first month of therapy, isolation of the organism by culture was successful in 14 of the cases. Except for three instances where there was a ten-fold increase in resistance to streptomycin, there was no significant change in reaction to the in vitro effect of streptomycin of the remaining strains.
By the end of the second month of therapy, not only did attempts at isolation of the tubercle bacilli from sputa or gastric contents reveal an increasing number of negative specimens, but also an increasing frequency and degree of resistance of the organisms to the chemotherapeutic agent. For instance, negative cultures had increased from 2 after the first month of therapy to 5 by the end of the second month. Along with this, 4 of the 11 isolated strains now showed a ten-fold or greater. increase in resistance. In 2 of these 4 resistant strains, resistance had increased 100-fold and 1000-fold, respectively.
During the third and fourth months of therapy the number of negative specimens and resistance of those organisms obtained by culture continued to increase. At the end of the third month, positive cultures were obtained in 7 of the 16 cases. In all but one instance, a ten-fold or greater in-crease in resistance was demonstrated. Two of the 6 resistant strains showed over a 2,000-fold increase, while tests on the remaining 4 of these 6 strains indicated that resistance had increased ten-fold in two instances, and 100-fold and 1,000-fold in the remaining two, respectively.
By the end of the course of therapy at the fourth month, 6 positive cultures were obtained. Tests of these organisms showed a ten-fold increase in resistance in two cases, 20-fold in two cases, 50-fold in one case and over 2,000-fold in the remaining case.
DISCUSSION
The results described above show a general tendency toward a steady reduction in the number of culturally positive sputa and gastric contents while the patients were under treatment with streptomycin. They further demonstrate the progressive development of significant streptomycin resistance of remaining organisms during such specific therapy. It should be stated at this point that the term "development of resistance" is loosely used throughout this report; the authors do not imply that a given genetic strain actually "develops" resistance but merely that resistant organisms appear. A discussion of whether this "resistance" depends upon the selection of gefietically resistant substrains in a culture, as has been shown with other micro-organisms and other chemotherapeutic agents, or whether true resistance of a given genetic strain of the Mycobacterium tuberculosis actually develops during exposure to streptomycin is beyond the scope of the present communication. Pyle (7) has very recently brought forth evidence which indicates that the former suggestion is correct.
It is of considerable interest that all organisms isolated after the third or fourth month of streptomycin therapy in the present study showed at least a ten-fold increase in resistance. This holds for 9 of the 16 cases investigated. In the remaining 7 cases, cultures had reverted to negative by this period.
Breakdown of the 9 strains of organisms isolated after the third or fourth month of therapy indicates the following degree of development of resistance when compared to the sensitivity of the strain isolated prior to treatment: (8) have shown that tuberculous infections produced in mice with streptomycin-resistant cultures of the tubercle bacillus were not suppressed by treatment of the animals with streptomycin.
Although it is not possible to attempt any definite correlation between the development of resistant organisms and the clinical course of the patients treated in the present study the following general statements, particularly with reference to the four cases in which resistance had increased at least 100-fold, may be made (9):
1. Definite relapse (clinical, radiologic, and bronchoscopic) occurred under treatment in one patient at about the time that the tested organisms showed a 2,000-fold increase in resistance.
2. Of the other three cases showing highly resistant strains during treatment, two continued to improve satisfactorily; the other case never showed significant improvement at any time.
3. One patient who relapsed under treatment (fever, increased expectoration, recurrence of grossly positive sputum, but no unfavorable x-ray change) and another patient who failed to maintain peak improvement, each yielded a strain of organism showing only a ten-fold increase in resistance.
It is evident from the foregoing data that it is impossible at this time to draw any definite correlation between in vitro resistance of the causative organism and the therapeutic course in the small number of cases treated. Further observations with respect to this correlation (9) and data concerning the resistance of organisms to strep-tomycin in the post-treatment period (10) will be recorded at a later date.
While investigators agree that tubercle bacilli develop a variable degree of resistance to streptomycin during therapy, they are not all in harmony as to the number which do so. Part of the disagreement, at least, may be due to two factors: first, definition of the term "resistance," and second, use of different technical procedures and media for the assay of resistance. Youmans et al. (4) first reported the development of resistance; they found that tubercle bacilli isolated from 8 of 12 patients after treatment with streptomycin showed a marked resistance to streptomycin. Resistance of 7 of these 8 strains, when compared with the resistance of strains isolated from the same patients before treatment, had increased 500-to 1,000-fold. (12) show that 78% of positive cultures obtained from streptomycin-treated patients at the end of 120 days contained organisms which were resistant to more than 10 mcg. of streptomycin per cc. (20-fold increase).
In striking contrast to the above observations which are in accord with the findings in the presently reported paper, Wallace and Fisher (13) found that only 4 (6) who have particularly stressed the necessity of using a low concentration of Tween 80 since this agent appears to possess a bacteriostatic action upon the growth of the tubercle bacillus.
In view of the disagreement noted above, it is also natural to inquire as to the possibility of selection of colonies of varying degrees of resistance to streptomycin from the same culture, a phenomenon previously described with non-acid fast organisms. In a number of instances, attempts were made to check the sensitivities of some of the strains of tubercle bacilli described in Table I , utilizing the same culture but different colonies. In some instances cultures isolated within a week or two of the reported strains were also employed. The results show that while the values obtained were in general agreement (within limits of technical error) with the values previously obtained, there were notable exceptions not only to the specific sensitivity value for a given date but also to the general trend. This point obviously needs further clarification since the authors are satisfied with the relative accuracy of the procedure outlined for determination of sensitivity.
SUMMARY
In vitro streptomycin sensitivity of tubercle bacilli isolated from sputa or gastric contents was determined in a group of 16 patients with pulmonary tuberculosis receiving 1.8 grams of streptomycin daily for a period of four months. In vitro tests were performed in a modified Dubos-Davis medium.
In all 16 cases, the strains of bacilli isolated prior to treatment were highly sensitive to streptomycin. Fourteen of these 16 strains were inhibited by 0.5 mcg. of streptomycin per cc., the remaining 2 strains were inhibited by 1.0 mcg. per cc.
Loss of sensitivity (ten-fold increase in resistance) began to appear by the end of the first month of therapy together with conversion of positive sputum or gastric washings to negative in other cases as determined by culture.
By the end of the third and fourth months of therapy, cultures were positive in only 9 of the 16 cases. Sensitivity tests of organisms from these 9 positive cultures indicated that all of them had developed a ten-fold or greater increase in resistance. Five of these 9 strains developed a 10-to 50-fold increase in resistance; the remaining 4 strains developed a 100 to greater than 2,000-fold increase in resistance.
It was not possible with this small group of patients to demonstrate conclusively a correlation between resistance to streptomycin and clinical course under therapy.
